Clinical Trial

Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)

Name: Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106) — clinical trial record (NCT07582237)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study

Trial Details

NCT Number	NCT07582237
Lead Sponsor	Kang Stem Biotech Co., Ltd.
Conditions	Dermatitis, Atopic
Enrollment	262 participants
Start Date	2021-10-05
Primary Completion	2028-08-21 (estimated)
Study Completion	2029-02-21 (estimated)
Updated on ClinicalTrials.gov	2026-05-12